A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer (S-TRAC)
This study is currently recruiting participants.
Verified June 2013 by Pfizer
Study NCT00375674
Information provided by Pfizer
First Received on September 12, 2006.
Last Updated on June 4, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
